Submitted by Anonymous (not verified) on 23 January 2026 - 12:48
Human medicines European public assessment report (EPAR): Ontruzant, trastuzumab, Date of authorisation: 15/11/2017, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ontruzant, trastuzumab, Date of authorisation: 15/11/2017, Revision: 16, Status: Authorised